Sharemaestro company-news research for IDEXX Laboratories, Inc. (IX1), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.

GER Germany Measured evidence

Company news sentiment

IX1 news sentiment

IDEXX Laboratories, Inc.

Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.

Weighted tone61Neutral is 50
Constructive news tone 43/100 evidence confidence 100% direct company focus 1 current stories across 1 publishers
Latest weekly closeEUR 514.80week of 7 Aug 2026
Dominant catalystMarket update72/100 classification confidence
News data statusHealthy0 duplicate stories removed

Current company news

News confirmed by price

Constructive news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.

Latest source headline IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test finance.yahoo.com · 11 Aug 2026 11:00

What supports the read

Direct evidence

1 current stories are mapped specifically to IX1.

Price response

Constructive news tone is being confirmed by positive weekly price action.

What tempers the read

Source breadth

Only 1 publisher currently contribute to the measured read.

61/100
Weighted toneConstructive news tone
43/100
Evidence confidencebuilding confidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories

News history

Tone and story flow over 21 days

Daily weighted evidence
11 Aug: 1 stories 11 Aug: tone 84, 1 stories 95505
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50

Evidence confidence

What supports the score

Measured separately from tone

Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.

Sample depth12
1.0 effective stories
Source breadth20
1 independent publishers
Direct relevance100
company-specific evidence share
Freshness75
recency-weighted evidence
Agreement0
requires at least 2 stories
Source independence0
lower publisher concentration

Price context

Sentiment against the 26-week price path

News confirmed by price

Constructive news tone is being confirmed by positive weekly price action.

23 Jan 2026: close 592.4, indexed 100.030 Jan 2026: close 567.6, indexed 95.806 Feb 2026: close 547.0, indexed 92.313 Feb 2026: close 532.2, indexed 89.820 Feb 2026: close 538.0, indexed 90.827 Feb 2026: close 557.0, indexed 94.006 Mar 2026: close 561.6, indexed 94.813 Mar 2026: close 499.0, indexed 84.220 Mar 2026: close 499.8, indexed 84.427 Mar 2026: close 491.1, indexed 82.903 Apr 2026: close 489.9, indexed 82.710 Apr 2026: close 487.5, indexed 82.317 Apr 2026: close 500.8, indexed 84.524 Apr 2026: close 500.8, indexed 84.501 May 2026: close 500.8, indexed 84.508 May 2026: close 500.8, indexed 84.515 May 2026: close 500.8, indexed 84.522 May 2026: close 478.2, indexed 80.729 May 2026: close 485.0, indexed 81.905 Jun 2026: close 487.4, indexed 82.312 Jun 2026: close 488.9, indexed 82.510 Jul 2026: close 480.3, indexed 81.117 Jul 2026: close 493.0, indexed 83.224 Jul 2026: close 478.1, indexed 80.731 Jul 2026: close 509.0, indexed 85.907 Aug 2026: close 514.8, indexed 86.9 19 Jun 2026: sentiment 4821 Jun 2026: sentiment 5222 Jun 2026: sentiment 5422 Jun 2026: sentiment 5222 Jun 2026: sentiment 5422 Jun 2026: sentiment 5426 Jun 2026: sentiment 5127 Jun 2026: sentiment 4929 Jun 2026: sentiment 4902 Jul 2026: sentiment 4902 Jul 2026: sentiment 4903 Jul 2026: sentiment 4903 Jul 2026: sentiment 4908 Jul 2026: sentiment 4617 Jul 2026: sentiment 5018 Jul 2026: sentiment 5019 Jul 2026: sentiment 5022 Jul 2026: sentiment 5122 Jul 2026: sentiment 5122 Jul 2026: sentiment 5123 Jul 2026: sentiment 5023 Jul 2026: sentiment 5024 Jul 2026: sentiment 5024 Jul 2026: sentiment 5027 Jul 2026: sentiment 5127 Jul 2026: sentiment 5129 Jul 2026: sentiment 5329 Jul 2026: sentiment 5202 Aug 2026: sentiment 5002 Aug 2026: sentiment 5005 Aug 2026: sentiment 56
23 Jan24 Apr07 Aug
Weekly close, indexedSentiment score
26-week price-13.1%latest close 514.8
Sentiment change+8available snapshot window
One-week response+1.1%Price digesting
Fair-value position+12.9%Near fair-value range
Sentiment-trend disagreement

News subjects

What is shaping the score

Market update
Market update841 stories · 100%

Source mix

Where the evidence comes from

0/100 independence
finance.yahoo.com841 stories · 100%

Recurring subjects

Subjects appearing most often

Current evidence
Veterinary Medicine1Pet Healthcare1Diagnostics1Cardiac Testing1

Earlier readings

How the score has changed

50 is the neutral baseline
ConstructiveBalanced or withheldCautious

Source headlines

The news behind the score

Showing 1-1 of 1

Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.

#184Tone
finance.yahoo.comDirect company coverage

IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test

New test brings quantitative cardiac assessment for cats and dogs into everyday workflows WESTBROOK, Maine, August 11, 2026--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst™ proBNP Test, the first and only dual-species, in-clinic test for NT-proBNP, expanding cardiac capabilities across its connected point-of-care and reference laboratory portfolio. The test measures a well-established biomarker used to evaluate heart disease in companion animals, a condition that affects approximately 1 in 6 cat

Cardiac TestingDiagnosticsPet HealthcareVeterinary Medicine
Published
11 Aug 2026 11:00
Catalyst
Market update
Evidence role
Direct company coverage
Duplicates
1 consolidated

How the page works

How to read the score

Tone is directional

It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.

Confidence is separate

Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.

Price is confirmation

Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.

Classification, not prediction

The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.

Evidence context